HeartWare Cancels Valtech Acquisition

January 31, 2016 | HeartWare International has cancelled its $929 million acquisition of Israeli company Valtech, the companies announced. “By stepping away from the acquisition, all of our resources will be dedicated to strengthening our existing business,” HeartWare said in a statement. This cancellation brings the total proceeds from acquisitions of Israeli high-tech companies in 2015 to $8.1 billion, down from the $9.02 billion figure recently reported by IVC Research Center. Valtech develops a number of non-invasive solutions for the treatment of heart conditions. It was founded in 1996 by CEO Yossi Gross and Yiftach Beinart.